Yield10 Bioscience Inc
NASDAQ:YTEN
Yield10 Bioscience Inc
Cash from Financing Activities
Yield10 Bioscience Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Yield10 Bioscience Inc
NASDAQ:YTEN
|
Cash from Financing Activities
$6.9m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
125%
|
CAGR 10-Years
92%
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Financing Activities
-$17.2B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-17%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Financing Activities
-$5.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Financing Activities
$21B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
23%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Financing Activities
-$562.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Financing Activities
-$1.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-88%
|
CAGR 10-Years
N/A
|
See Also
What is Yield10 Bioscience Inc's Cash from Financing Activities?
Cash from Financing Activities
6.9m
USD
Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's Cash from Financing Activities amounts to 6.9m USD.
What is Yield10 Bioscience Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
92%
The average annual Cash from Financing Activities growth rates for Yield10 Bioscience Inc have been -2% over the past three years , 125% over the past five years , and 92% over the past ten years .